Drug Development and Therapeutics is an open access journal focusing on breakthroughs and advances in drug discovery, pharmacology, and therapeutic applications. It covers all stages of pharmaceutical research, from initial conception to clinical trials and post-market surveillance.
This journal explores a wide spectrum of therapeutic areas including oncology, cardiology, neurology, and infectious diseases, focusing on novel drug targets, mechanisms of action, and clinical efficacy. Topics covered encompass drug formulation, delivery systems, and personalized medicine approaches, ensuring new therapeutic molecules reach patients. It emphasizes research aimed at optimizing drug safety profiles and addressing unmet medical needs. The primary audience includes pharmaceutical scientists, clinicians, pharmacologists, and researchers engaged in discovering new therapeutic interventions.
By publishing original research articles, reviews, and perspectives, Drug Development and Therapeutics contributes to accelerating the translation of scientific discoveries into clinical practice. It welcomes submissions highlighting innovative strategies for drug design, preclinical evaluation, and clinical development, emphasizing the potential to improve patient outcomes and address global health challenges. As an open-access platform, the journal ensures its findings are readily available, boosting knowledge sharing and cooperation within the global research community.